Tech Company Financing Transactions

Conatus Pharmaceuticals Funding Round

AgeChem Venture Fund, Aberdare Ventures and Advent Venture Partners joined a $20 million Series B funding round for Conatus Pharmaceuticals. The round was announced by the company on 2/13/2011.

Transaction Overview

Company Name
Conatus Pharmaceuticals
Announced On
2/13/2011
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors

AgeChem Venture Fund (Lead Investor) (Louis Lacasse)

Aberdare Ventures (Paul Klingenstein)

Advent Venture Partners (Patrick Lee)

Bay City Capital (William Gerber)

Glide Healthcare Partners

Roche Venture Fund

Proceeds Purpose
Conatus will use the proceeds to advance the clinical development of CTS-1027, a novel clinical-stage drug candidate the Company has licensed from F. Hoffman-La Roche, Ltd. and is the subject of multiple Phase 2 clinical trials in hepatitis C (HCV)-infected patients.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
16745 West Bernardo Dr. 200
San Diego, CA 92127
USA
Phone
(858) 376-2600
Website
www.conatuspharma.com
Email Address
[email protected]
Overview
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Profile
Conatus Pharmaceuticals LinkedIn Company Profile
Social Media
Conatus Pharmaceuticals Company Twitter Account
Company News
Conatus Pharmaceuticals News
Facebook
Conatus Pharmaceuticals on Facebook
YouTube
Conatus Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steven Mento
  Steven Mento LinkedIn Profile  Steven Mento Twitter Account  Steven Mento News  Steven Mento on Facebook
Chief Operating Officer
Keith Marshall
  Keith Marshall LinkedIn Profile  Keith Marshall Twitter Account  Keith Marshall News  Keith Marshall on Facebook
VP - Finance
Michelle Vandertie
  Michelle Vandertie LinkedIn Profile  Michelle Vandertie Twitter Account  Michelle Vandertie News  Michelle Vandertie on Facebook
VP - R & D
Alfred Spada
  Alfred Spada LinkedIn Profile  Alfred Spada Twitter Account  Alfred Spada News  Alfred Spada on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/11/2011: Gen9 venture capital transaction
Next: 2/13/2011: Telogis venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.